从新冠疫情视角看乳腺癌差异
Breast Cancer Disparities Through the Lens of the COVID-19 Pandemic.
作者信息
Newman Lisa, Fejerman Laura, Pal Tuya, Mema Eralda, McGinty Geraldine, Cheng Alex, Levy Mia, Momoh Adeyiza, Troester Melissa, Schneider Bryan, McNeil Lorna, Davis Melissa, Babagbemi Kemi, Hunt Kelly
机构信息
Department of Surgery, Weill Cornell Medicine, New York, NY USA.
Department of Public Health Sciences, University of California Davis Health, Sacramento, CA USA.
出版信息
Curr Breast Cancer Rep. 2021;13(3):110-112. doi: 10.1007/s12609-021-00419-x. Epub 2021 Aug 6.
PURPOSE OF REVIEW
The emergency medicine and critical care needs of the COVID-19 pandemic forced a sudden and dramatic disruption of cancer screening and treatment programs in the USA during the winter and spring of 2020. This review commentary addresses the impact of the pandemic on racial/ethnic minorities such as African Americans and Hispanic-Latina Americans, with a focus on factors related to breast cancer.
RECENT FINDINGS
African Americans and Hispanic-Latina Americans experienced disproportionately higher morbidity and mortality from COVID-19; many of the same socioeconomic and tumor biology/genetic factors that explain breast cancer disparities are likely to account for COVID-19 outcome disparities.
SUMMARY
The breast cancer clinical and research community should partner with public health experts to ensure participation of diverse patients in COVID-19 treatment trials and vaccine programs and to overcome COVID-19-related breast health management delays that are likely to have been magnified among African Americans and Hispanic-Latina Americans.
综述目的
2020年冬春之际，美国新冠疫情对急诊医学和重症监护的需求，迫使癌症筛查和治疗项目突然遭受巨大干扰。本综述评论探讨了疫情对非裔美国人和西班牙裔拉丁裔美国人等种族/族裔少数群体的影响，重点关注与乳腺癌相关的因素。
最新发现
非裔美国人和西班牙裔拉丁裔美国人感染新冠病毒后的发病率和死亡率高得不成比例；许多解释乳腺癌差异的社会经济和肿瘤生物学/遗传因素，可能也是导致新冠病毒感染结果差异的原因。
总结
乳腺癌临床和研究领域应与公共卫生专家合作，确保不同患者参与新冠治疗试验和疫苗项目，并克服与新冠相关的乳腺健康管理延误，这种延误在非裔美国人和西班牙裔拉丁裔美国人中可能更为严重。
Zotero 插件